A novel therapeutic vaccine of mouse GM-CSF surface modified MB49 cells against metastatic bladder cancer

Journal of Urology

Volumn 187, Issue 3, 2012, Pages 1071-1079

  Zhang, Xinji ^a   Shi, Xiaojun ^a   Li, Jinlong ^a   Hu, Zhiming ^a   Zhou, Dong ^c   Gao, Jimin ^b   Tan, Wanlong ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b WENZHOU MEDICAL UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

cancer vaccines; granulocyte macrophage colony stimulating factor; mice; neoplasm metastasis; urinary bladder

Indexed keywords

CYTOKERATIN 7; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; STREPTAVIDIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLADDER CANCER; BLADDER METASTASIS; BLOOD; CANCER CELL; CANCER LOCALIZATION; CANCER SURVIVAL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG CYTOTOXICITY; FEMALE; FLOW CYTOMETRY; HINDLIMB; IMMUNOHISTOCHEMISTRY; LUNG METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; SPLEEN CELL; TUMOR GROWTH; TUMOR IMMUNITY;

ADAPTIVE IMMUNITY; ANALYSIS OF VARIANCE; ANIMALS; CANCER VACCINES; CELL LINE, TUMOR; FEMALE; FLOW CYTOMETRY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MICE; MICE, INBRED C57BL; NEOPLASM INVASIVENESS; STREPTAVIDIN; T-LYMPHOCYTES, CYTOTOXIC; URINARY BLADDER NEOPLASMS;

EID: 84862805746     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2011.10.126     Document Type: Article

References (21)

1. S.A. Hussain, N.D. James The systemic treatment of advanced and metastatic bladder cancer Lancet Oncol 4 2003 489
2. E.M. Messing, T.B. Young, V.B. Hunt Comparison of bladder cancer outcome in men undergoing hematuria home screening versus those with standard clinical presentations Urology 45 1995 387
3. W.F. Whitmore Jr Management of invasive bladder neoplasms Semin Urol 1 1983 34
4. F.M. Hofman, A. Stathopoulos, C.A. Kruse Immunotherapy of malignant gliomas using autologous and allogeneic tissue cells Anticancer Agents Med Chem 10 2010 462
5. R. Pul, D. Moharregh-Khiabani, J. Skuljec Glatiramer acetate modulates TNF-alpha and IL-10 secretion in microglia and promotes their phagocytic activity J Neuroimmune Pharmacol 6 2010 381
6. N.P. Singh, E.S. Yolcu, D.D. Taylor A novel approach to cancer immunotherapy: tumor cells decorated with CD80 generate effective antitumor immunity Cancer Res 63 2003 4067
7. R. Philip, B. Clary, E. Brunette Gene modification of primary tumor cells for active immunotherapy of human breast and ovarian cancer Clin Cancer Res 2 1996 59
8. K.A. Tolba, W.J. Bowers, S.P. Hilchey Development of herpes simplex virus-1 amplicon-based immunotherapy for chronic lymphocytic leukemia Blood 98 2001 287
9. E. Galanis, R. Vile, S.J. Russell Delivery systems intended for in vivo gene therapy of cancer: targeting and replication competent viral vectors Crit Rev Oncol Hematol 38 2001 177
10. Z. Hu, W. Tan, L. Zhang A novel immunotherapy for superficial bladder cancer by intravesical immobilization of GM-CSF J Cell Mol Med 14 2010 1836
11. D.N. Hart Dendritic cells: unique leukocyte populations which control the primary immune response Blood 90 1997 3245
12. R.M. Steinman The dendritic cell system and its role in immunogenicity Annu Rev Immunol 9 1991 271
13. W. Yin, Z. Hu, Q. He A novel therapeutic vaccine of GM-CSF/TNF alpha surface-modified RM-1 cells against the orthotopic prostatic cancer Vaccine 28 2010 4937
14. N.E. Fleshner, H.W. Herr, A.K. Stewart The National Cancer Data Base report on bladder carcinoma The American College of Surgeons Commission on Cancer and the American Cancer Society Cancer 78 1996 1505
15. D.C. Chade, P.M. Andrade, R.C. Borra Histopathological characterization of a syngeneic orthotopic murine bladder cancer model Int Braz J Urol 34 2008 220
16. M.P. Cid, J.A. Ortiz Rey, I. Anton Badiola Coordinated expression of cytokeratin 7 and 20 in transitional carcinoma of the bladder: diagnostic usefulness Actas Urol Esp 26 2002 279
17. A. Loskog, C. Ninalga, T. Hedlund Optimization of the MB49 mouse bladder cancer model for adenoviral gene therapy Lab Anim 39 2005 384
18. S. Yei, R.M. Bartholomew, P. Pezzoli Novel membrane-bound GM-CSF vaccines for the treatment of cancer: generation and evaluation of mbGM-CSF mouse B16F10 melanoma cell vaccine Gene Ther 9 2002 1302
19. J. Vieweg, A. Jackson Antigenic targets for renal cell carcinoma immunotherapy Expert Opin Biol Ther 4 2004 1791
20. J. Nemunaitis, D. Sterman, D. Jablons Granulocyte-macrophage colony-stimulating factor gene-modified autologous tumor vaccines in non-small-cell lung cancer J Natl Cancer Inst 96 2004 326
21. K. Shimizu, R.C. Fields, M. Giedlin Systemic administration of interleukin 2 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines Proc Natl Acad Sci U S A 96 1999 2268